Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increased trend of outsourcing laboratory testing services
3.2.1.2 Rising advancements in bioanalytical technology
3.2.1.3 Growing drug development and approval processes
3.2.1.4 Increasing volume of ongoing research activities and clinical trials
3.2.2 Industry pitfalls & challenges
3.2.2.1 Complex regulatory framework for maintaining laboratories
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive positioning matrix
4.4 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Molecule Type, 2018 – 2032 ($ Million)
5.1 Key trends
5.2 Small molecule
5.3 Large molecule
Chapter 6 Market Estimates and Forecast, By Test Type, 2018 – 2032 ($ Million)
6.1 Key trends
6.2 DMPK testing
6.3 Biomarker testing
6.4 Virology testing
6.4.1 In-vivo virology testing
6.4.2 In-vitro virology testing
6.5 Serology testing
6.6 Immunogenicity testing
6.7 Other test types
Chapter 7 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Million)
7.1 Key trends
7.2 Oncology
7.3 Neurology
7.4 Infectious diseases
7.5 Gastroenterology
7.6 Cardiology
7.7 Other applications
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Million)
8.1 Key trends
8.2 Pharmaceutical & biotechnology companies
8.3 Contract research organizations
8.4 Research & academic institutes
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 BioAgilytix
10.2 Charles River Laboratories, Inc.
10.3 Eurofins Scientific
10.4 Frontage Labs
10.5 ICON Plc
10.6 Intertek Group Plc
10.7 Labcorp Drug Development
10.8 Pace Analytical Services LLC
10.9 SGS Société Générale de Surveillance SA
10.10 Syneos Health
10.11 Thermo Fisher Scientific Inc.
10.12 WuXi AppTec
